Tigecycline For Injection Usp 50 Mg Dry Powder Injections Vial

Tigecycline For Injection Usp 50 Mg Dry Powder Injections Vial

Product Name :

Voriconazole Injection IP 200 Mg

Available Strength :

200 mg

Packing :

Vial / As per your requirement

Pack Insert/ Leaflet :

Available upon request

Therapeutical Use :

Antifungal

Production Capacity :

Available on request

Description:

What is Tigecycline For Injection USP 50 Mg?

Tigecycline For Injection USP 50 Mg is a dry powder injectable antibiotic containing tigecycline, a glycylcycline antibacterial agent related to the tetracycline class. It is used in selected clinical settings to treat certain bacterial infections caused by susceptible organisms. Its use should be guided by the approved product information, local antimicrobial guidance and assessment by a qualified healthcare professional.

Uses and Indications

Tigecycline is used for certain infections caused by susceptible bacteria. Depending on the approved product information and local clinical guidance, indications may include:

  • Complicated skin and soft-tissue infections.

  • Complicated intra-abdominal infections.

  • Community-acquired bacterial pneumonia in eligible patients.

The approved indications and restrictions vary by jurisdiction. Tigecycline is not appropriate for every bacterial infection, and its use should be guided by the infection site, susceptibility information and clinical assessment.

Potential Benefits

  • Antibacterial activity: Acts against selected susceptible Gram-positive and Gram-negative bacteria, as well as certain anaerobic organisms.

  • Specified strength: The supplied product strength is 50 Mg.

  • Dry powder presentation: Intended for preparation according to the approved product-specific instructions.

  • International sourcing support: Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries for international buyers.

Side Effects

Possible adverse effects associated with tigecycline include:

Commonly reported effects

  • Nausea

  • Vomiting

  • Diarrhoea

  • Abdominal discomfort

Potentially serious effects

  • Severe allergic reactions

  • Pancreatitis

  • Liver-related adverse effects

  • Significant coagulation abnormalities

  • Severe or persistent diarrhoea

Tigecycline has important safety warnings, and its suitability should be assessed by a qualified healthcare professional. Seek prompt medical attention for severe or unexpected symptoms.

How Does Tigecycline Work?

Tigecycline binds to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis and preventing susceptible bacteria from producing proteins required for growth and survival. Its activity covers selected bacterial organisms, but susceptibility varies. It does not treat viral infections such as influenza or the common cold.

Dosage Guidelines

  • Supplied strength: 50 Mg.

  • The prescribed regimen depends on the approved indication, patient factors and applicable product information.

  • Reconstitution, further dilution and administration must follow the approved product-specific instructions.

  • Treatment should be prescribed and monitored by a qualified healthcare professional.

Do not infer the diluent, reconstitution volume, final concentration, infusion duration or stability after preparation from the vial strength alone.

When Not to Use

Tigecycline may be unsuitable for patients with:

  • Known hypersensitivity to tigecycline or related tetracycline-class antibiotics, or any formulation component.

  • A contraindication specified in the approved product information.

  • Clinical circumstances in which the risks outweigh the expected benefits.

Pregnancy, paediatric use and significant hepatic impairment require particular attention to the applicable prescribing information and clinical guidance.

Drug and Product Interactions

Tigecycline may interact with certain medicines or require additional monitoring when used alongside them. Examples include:

  • Warfarin: Coagulation parameters may require monitoring.

  • Calcineurin inhibitors such as tacrolimus: Clinical monitoring may be needed.

  • Other medicines affecting liver function or coagulation: Review the patient’s treatment and monitoring needs.

A healthcare professional should review all concurrent medicines. Drug interactions are distinct from physical compatibility; do not mix tigecycline with other injectable products unless compatibility is established in the approved instructions.

Safety Advice

  • Use only under qualified medical supervision.

  • Select treatment based on the infection and relevant susceptibility information where available.

  • Monitor for gastrointestinal adverse effects and other clinically significant reactions.

  • Inform the treating team about allergies, pregnancy status where relevant, liver problems and current medicines.

  • Do not use a vial if its packaging or product identification is compromised.

General Instructions

  • Verify the product name, strength and approved product documentation before use.

  • Follow the specified reconstitution, dilution and administration instructions.

  • Do not assume compatibility with other injectable medicines.

  • Observe the approved handling and in-use requirements.

  • Confirm all product-specific details against the approved product specification.

Special Dietary and Lifestyle Tips

There is no specific diet that treats a bacterial infection. General supportive measures may include:

  • Maintain fluid intake as advised by the treating healthcare professional.

  • Follow the prescribed treatment and monitoring plan.

  • Inform the treating team about all medicines and supplements being used.

  • Report persistent vomiting, severe diarrhoea or worsening symptoms promptly.

  • Do not change or stop antibiotic treatment without medical advice.

Comparison with Other Treatments

Treatment General characteristics
Tigecycline Glycylcycline antibiotic used for selected approved bacterial infections.
Tetracyclines Related antibiotic class with different indications, activity profiles and formulation options.
Carbapenems Broad-spectrum beta-lactam antibiotics used for selected serious infections.
Other antibiotics Selection depends on the infection site, organism susceptibility, patient factors and clinical guidance.

These treatments are not automatically interchangeable. Tigecycline may not be suitable for infections where another antibiotic has a better-established clinical role.

Precautions and Warnings

  • Tigecycline should be reserved for approved indications where its benefits outweigh its risks.

  • It is not suitable for all bloodstream infections or bacterial infections.

  • Monitor for severe gastrointestinal symptoms, pancreatitis, liver-related effects and coagulation abnormalities as clinically appropriate.

  • Consider the approved warnings for pregnancy, children and patients with hepatic impairment.

  • Antibiotic selection should follow applicable antimicrobial stewardship guidance.

  • Product details should be confirmed against the approved product specification.

Can I Use It With Other Medicines or Antibiotics?

Tigecycline may be prescribed alongside other medicines when clinically indicated, but the combination requires professional review.

  • Check potential interactions and monitoring requirements with a qualified healthcare professional.

  • Combination antibiotic treatment should be based on the clinical indication and relevant evidence.

  • Do not mix injectable medicines in the same container unless compatibility has been established.

  • Follow the approved product instructions for preparation and administration.

Storage

Store Tigecycline For Injection USP 50 Mg according to the approved product label and manufacturer’s instructions. Specific storage conditions, light-protection requirements, post-reconstitution stability and in-use storage limits should be confirmed from the applicable product documentation rather than assumed.

Frequently Asked Questions

1. What is Tigecycline For Injection USP 50 Mg used for?

It is an injectable antibiotic used for selected bacterial infections covered by its approved product information.

2. What is the supplied strength?

The supplied strength is 50 Mg.

3. What is the dosage form?

The supplied dosage form is dry powder injection in a vial.

4. Does tigecycline treat viral infections?

No. Tigecycline is an antibacterial medicine and does not treat viral infections such as influenza or the common cold.

5. Does tigecycline require medical supervision?

Yes. It should be prescribed and monitored by a qualified healthcare professional.

6. Can tigecycline be mixed with other injectable medicines?

Only when compatibility has been confirmed in the approved product instructions for the specific medicines and preparation conditions.

7. Can international buyers enquire through Kelar Pharmachem India?

Kelar Pharmachem India supports pharmaceutical sourcing and export enquiries. Availability, packing, documentation and supply terms can be confirmed on request.

Scroll to Top